Skip to main content
Title Pub Year Sort ascending Author SearchLink
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective 2014 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Nuclear Medicine and Cardiology Division of Cardiovascular Medical Cen
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
PloS one
Periodical, Abbrev.
PLoS One
Pub Date Free Form
18-Mar
Volume
9
Issue
3
Start Page
e92001
Other Pages
Notes
LR: 20151119; JID: 101285081; 0Z5B2CJX4D (Fluorodeoxyglucose F18); OID: NLM: PMC3958434; 2014 [ecollection]; 2013/11/22 [received]; 2014/02/15 [accepted]; 2014/03/18 [epublish]; epublish
Place of Publication
United States
ISSN/ISBN
1932-6203; 1932-6203
Accession Number
PMID: 24642729
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1371/journal.pone.0092001 [doi]
Output Language
Unknown(0)
PMID
24642729
Abstract
OBJECTIVE: Gastroesophageal reflux disease (GERD) is associated with bothersome symptoms and neoplastic progression into Barrett's esophagus and esophageal adenocarcinoma. We aim to determine the correlation between GERD, esophageal inflammation and obesity with 18F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). METHODS: We studied 458 subjects who underwent a comprehensive health check-up, which included an upper gastrointestinal endoscopy, FDG PET/CT and complete anthropometric measures. GERD symptoms were evaluated with Reflux Disease Questionnaire. Endoscopically erosive esophagitis was scored using the Los Angeles classification system. Inflammatory activity, represented by standardized uptake values (SUVmax) of FDG at pre-determined locations of esophagus, stomach and duodenum, were compared. Association between erosive esophagitis, FDG activity and anthropometric evaluation, including body mass index (BMI), waist circumference, visceral and subcutaneous adipose tissue volumes were analyzed. RESULTS: Subjects with erosive esophagitis (n = 178, 38.9%) had significantly higher SUVmax at middle esophagus (2.69+/-0.74 vs. 2.41+/-0.57, P<.001 and="" esophagogastric="" junction="" vs.="" p="" marginally="" higher="" at="" upper="" esophageal="" sphincter="" but="" not="" in="" stomach="" or="" duodenum.="" the="" severity="" of="" erosive="" esophagitis="" correlated="" with="" suvmax="" subjects="" barrett="" esophagus="" had="" highest="" middle="" junction.="" heartburn="" positively="" oesophagus="" .262="" using="" multivariate="" regression="" analyses="" age="" .027="" total="" cholesterol="" level="" .003="" alcohol="" drinking="" .03="" subcutaneous="" adipose="" tissue="" bmi="" waist="" circumference="" were="" independently="" associated="" respective="" locations.="" conclusions:="" inflammation="" demonstrated="" by="" fdg="" pet="" correlates="" endoscopic="" findings="" symptomatology="" gerd.="" obesity="" markers="" both="" visceral="" general="" are="" independent="" determinants="" inflammation.="">
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Wu,Y.W., Tseng,P.H., Lee,Y.C., Wang,S.Y., Chiu,H.M., Tu,C.H., Wang,H.P., Lin,J.T., Wu,M.S., Yang,W.S.
Original/Translated Title
URL
Date of Electronic
20140318
PMCID
PMC3958434
Editors
Electronic cigarettes and conventional cigarette use among U.S. adolescents: a cross-sectional study 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
JAMA pediatrics
Periodical, Abbrev.
JAMA Pediatr.
Pub Date Free Form
Jul
Volume
168
Issue
7
Start Page
610
Other Pages
617
Notes
LR: 20150515; GR: CA-060121/CA/NCI NIH HHS/United States; GR: CA-113710/CA/NCI NIH HHS/United States; GR: R01 CA061021/CA/NCI NIH HHS/United States; GR: R25 CA113710/CA/NCI NIH HHS/United States; JID: 101589544; CIN: JAMA Pediatr. 2014 Aug;168(8):776-7. P
Place of Publication
United States
ISSN/ISBN
2168-6211; 2168-6203
Accession Number
PMID: 24604023
Language
eng
SubFile
Journal Article; Research Support, N.I.H., Extramural; AIM; IM
DOI
1840772 [pii]
Output Language
Unknown(0)
PMID
24604023
Abstract
OBJECTIVE: To examine e-cigarette use and conventional cigarette smoking. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analyses of survey data from a representative sample of US middle and high school students in 2011 (n = 17 353) and 2012 (n = 22 529) who completed the 2011 and 2012 National Youth Tobacco Survey. EXPOSURES: Ever and current e-cigarette use. MAIN OUTCOMES AND MEASURES: Experimentation with, ever, and current smoking, and smoking abstinence. RESULTS: Among cigarette experimenters (1 puff), ever e-cigarette use was associated with higher odds of ever smoking cigarettes (100 cigarettes; odds ratio [OR] = 6.31; 95% CI, 5.39-7.39) and current cigarette smoking (OR = 5.96; 95% CI, 5.67-6.27). Current e-cigarette use was positively associated with ever smoking cigarettes (OR = 7.42; 95% CI, 5.63-9.79) and current cigarette smoking (OR = 7.88; 95% CI, 6.01-10.32). In 2011, current cigarette smokers who had ever used e-cigarettes were more likely to intend to quit smoking within the next year (OR = 1.53; 95% CI, 1.03-2.28). Among experimenters with conventional cigarettes, ever use of e-cigarettes was associated with lower 30-day (OR = 0.24; 95% CI, 0.21-0.28), 6-month (OR = 0.24; 95% CI, 0.21-0.28), and 1-year (OR = 0.25; 95% CI, 0.21-0.30) abstinence from cigarettes. Current e-cigarette use was also associated with lower 30-day (OR = 0.11; 95% CI, 0.08-0.15), 6-month (OR = 0.11; 95% CI, 0.08-0.15), and 1-year (OR = 0.12; 95% CI, 0.07-0.18) abstinence. Among ever smokers of cigarettes (100 cigarettes), ever e-cigarette use was negatively associated with 30-day (OR = 0.61; 95% CI, 0.42-0.89), 6-month (OR = 0.53; 95% CI, 0.33-0.83), and 1-year (OR = 0.32; 95% CI, 0.18-0.56) abstinence from conventional cigarettes. Current e-cigarette use was also negatively associated with 30-day (OR = 0.35; 95% CI, 0.18-0.69), 6-month (OR = 0.30; 95% CI, 0.13-0.68), and 1-year (OR = 0.34; 95% CI, 0.13-0.87) abstinence. CONCLUSIONS AND RELEVANCE: Use of e-cigarettes was associated with higher odds of ever or current cigarette smoking, higher odds of established smoking, higher odds of planning to quit smoking among current smokers, and, among experimenters, lower odds of abstinence from conventional cigarettes. Use of e-cigarettes does not discourage, and may encourage, conventional cigarette use among U.S. adolescents.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Dutra,L.M., Glantz,S.A.
Original/Translated Title
URL
Date of Electronic
PMCID
PMC4142115
Editors
Analysis of bisphenol A diglycidyl ether (BADGE) and its hydrolytic metabolites in biological specimens by high-performance liquid chromatography and tandem mass spectrometry 2014 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.; Departm
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Journal of chromatography.B, Analytical technologies in the biomedical and life sciences
Periodical, Abbrev.
J.Chromatogr.B.Analyt Technol.Biomed.Life.Sci.
Pub Date Free Form
15-Aug
Volume
965
Issue
Start Page
33
Other Pages
38
Notes
CI: Copyright (c) 2014; JID: 101139554; 0 (Benzhydryl Compounds); 0 (Epoxy Compounds); F3XRM1NX4H (2,2-bis(4-glycidyloxyphenyl)propane); OTO: NOTNLM; 2013/12/13 [received]; 2014/05/03 [revised]; 2014/06/06 [accepted]; 2014/06/18 [aheadofprint]; ppublish
Place of Publication
Netherlands
ISSN/ISBN
1873-376X; 1570-0232
Accession Number
PMID: 24980807
Language
eng
SubFile
Journal Article; IM
DOI
10.1016/j.jchromb.2014.06.005 [doi]
Output Language
Unknown(0)
PMID
24980807
Abstract
Due to its cytotoxicity, genotoxicity, and adipogenicity observed in in vitro studies, bisphenol A diglycidyl ether (BADGE) may pose a health risk to humans. Quantifying BADGE exposure is an essential step to assess potential health risks associated with this ubiquitous compound widely used in certain plastic products. Due to the lack of endogenous sources for BADGE, bio-monitoring of BADGE and/or its hydrolytic metabolites (BADGE.H2O and BADGE.2H2O) can be a useful means to measure exposure. In this study, we developed a highly specific and sensitive method to measure BADGE, BADGE.H2O and BADGE.2H2O in plasma and urine, using a fast liquid-liquid extraction technique followed by a high-performance liquid chromatography and positive electrospray tandem mass spectrometry (LC-ESI-MS/MS) method. The method can quantify BADGE, BADGE.H2O and BADGE.2H2O with lower limits of quantification (LLOQ) of 0.05, 0.05 and 0.2 ng/ml, respectively. The percentage deviation of mean calculated concentrations from target concentrations was within 20%, variations across repeated analyses were within 15%, and mean extraction recovery was higher than 51.4% for all the three analytes in both plasma and urine matrices. The method has been applied to venous blood samples, cord blood samples, and urine samples collected from 9 to 14 adult volunteers. Results showed that concentrations of BADGE were lower than LLOQ in all of these samples except one urine sample. Low levels of BADGE.H2O from 0.108 to 0.222 ng/ml were observed in four venous blood samples and one urine sample (0.187 ng/ml). In contrast, concentrations of BADGE.2H2O were higher than LLOQ, varying from 0.660 to 303.593 ng/ml, in all the 10 venous blood samples and 1 cord blood sample (0.592 ng/ml) and two urine samples (0.200 and 0.306 ng/ml). The results suggest that bio-monitoring of blood and urine for BADGE exposure should focus on the hydrolysis derivatives of BADGE, mainly in the form of BADGE.2H2O.
Descriptors
Links
Book Title
Database
Publisher
Elsevier B.V
Data Source
Authors
Chang,Y., Nguyen,C., Paranjpe,V.R., Gilliland,F., Zhang,J.J.
Original/Translated Title
URL
Date of Electronic
20140618
PMCID
Editors
Ebola virus disease outbreak - Nigeria, July-September 2014 2014
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
MMWR.Morbidity and mortality weekly report
Periodical, Abbrev.
MMWR Morb.Mortal.Wkly.Rep.
Pub Date Free Form
3-Oct
Volume
63
Issue
39
Start Page
867
Other Pages
872
Notes
JID: 7802429; ppublish
Place of Publication
United States
ISSN/ISBN
1545-861X; 0149-2195
Accession Number
PMID: 25275332
Language
eng
SubFile
Journal Article; IM
DOI
mm6339a5 [pii]
Output Language
Unknown(0)
PMID
25275332
Abstract
On July 20, 2014, an acutely ill traveler from Liberia arrived at the international airport in Lagos, Nigeria, and was confirmed to have Ebola virus disease (Ebola) after being admitted to a private hospital. This index patient potentially exposed 72 persons at the airport and the hospital. The Federal Ministry of Health, with guidance from the Nigeria Centre for Disease Control (NCDC), declared an Ebola emergency. Lagos, (pop. 21 million) is a regional hub for economic, industrial, and travel activities and a setting where communicable diseases can be easily spread and transmission sustained. Therefore, implementing a rapid response using all available public health assets was the highest priority. On July 23, the Federal Ministry of Health, with the Lagos State government and international partners, activated an Ebola Incident Management Center as a precursor to the current Emergency Operations Center (EOC) to rapidly respond to this outbreak. The index patient died on July 25; as of September 24, there were 19 laboratory-confirmed Ebola cases and one probable case in two states, with 894 contacts identified and followed during the response. Eleven patients with laboratory-confirmed Ebola had been discharged, an additional patient was diagnosed at convalescent stage, and eight patients had died (seven with confirmed Ebola; one probable). The isolation wards were empty, and 891 (all but three) contacts had exited follow-up, with the remainder due to exit on October 2. No new cases had occurred since August 31, suggesting that the Ebola outbreak in Nigeria might be contained. The EOC, established quickly and using an Incident Management System (IMS) to coordinate the response and consolidate decision making, is largely credited with helping contain the Nigeria outbreak early. National public health emergency preparedness agencies in the region, including those involved in Ebola responses, should consider including the development of an EOC to improve the ability to rapidly respond to urgent public health threats.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Shuaib,F., Gunnala,R., Musa,E.O., Mahoney,F.J., Oguntimehin,O., Nguku,P.M., Nyanti,S.B., Knight,N., Gwarzo,N.S., Idigbe,O., Nasidi,A., Vertefeuille,J.F., Centers for Disease Control and Prevention (CDC)
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms 2014 Centre of Microbial and Plant Genetics, CMPG, KU Leuven, Kasteelpark Arenberg 20, Box 2460, 3001 Heverlee, Belgium.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
The Journal of antimicrobial chemotherapy
Periodical, Abbrev.
J.Antimicrob.Chemother.
Pub Date Free Form
Apr
Volume
69
Issue
4
Start Page
1035
Other Pages
1044
Notes
JID: 7513617; 0 (Androstenes); 0 (Antifungal Agents); 0 (Echinocandins); 7NFE54O27T (Toremifene); 7XU7A7DROE (Amphotericin B); F0XDI6ZL63 (caspofungin); K7V8Y90G0H (perhexiline maleate); KU65374X44 (Perhexiline); N295J34A25 (drospirenone); OTO: NOTNLM; 20
Place of Publication
England
ISSN/ISBN
1460-2091; 0305-7453
Accession Number
PMID: 24284780
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1093/jac/dkt449 [doi]
Output Language
Unknown(0)
PMID
24284780
Abstract
OBJECTIVES: Biofilms of Candida species, often formed on medical devices, are generally resistant to currently available antifungal drugs. The aim of this study was to identify compounds that increase the activity of amphotericin B and caspofungin, commonly used antifungal agents, against Candida biofilms. METHODS: A library containing off-patent drugs was screened for compounds, termed enhancers, that increase the in vitro activity of amphotericin B against Candida albicans biofilms. Biofilms were grown in 96-well plates and growth was determined by the cell titre blue assay. Synergy between identified enhancers and antifungal agents was further characterized in vitro using fractional inhibitory concentration index (FICI) values and in vivo using a worm biofilm infection model. In light of the application of these enhancers onto implants, their possible effect on the growth potential of MG63 osteoblast-like cells was assessed. RESULTS: Pre-incubation of C. albicans biofilms with subinhibitory concentrations of the enhancers drospirenone, perhexiline maleate or toremifene citrate significantly increased the activity of amphotericin B or caspofungin (FICI
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Delattin,N., De Brucker,K., Vandamme,K., Meert,E., Marchand,A., Chaltin,P., Cammue,B.P., Thevissen,K.
Original/Translated Title
URL
Date of Electronic
20131127
PMCID
Editors
Ultrasound detection of vascular decompression bubbles: the influence of new technology and considerations on bubble load 2014 SLB Consulting, C/O The Barn, Manor House Wynd, Winton, Cumbria, CA17 4HL, UK, Phone: +44-(0)771-442-2042, E-mail: lesley@chapelclose20.fsnet.co.uk.; Department of Environmental Physiology, School of Technology and Health, Royal Institute of Technology, S
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Diving and hyperbaric medicine
Periodical, Abbrev.
Diving.Hyperb.Med.
Pub Date Free Form
Mar
Volume
44
Issue
1
Start Page
35
Other Pages
44
Notes
LR: 20141212; JID: 101282742; OTO: NOTNLM; 2013/08/02 [received]; 2014/01/26 [accepted]; ppublish
Place of Publication
Australia
ISSN/ISBN
1833-3516; 1833-3516
Accession Number
PMID: 24687484
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; Review; IM
DOI
Output Language
Unknown(0)
PMID
24687484
Abstract
INTRODUCTION: Diving often causes the formation of 'silent' bubbles upon decompression. If the bubble load is high, then the risk of decompression sickness (DCS) and the number of bubbles that could cross to the arterial circulation via a pulmonary shunt or patent foramen ovale increase. Bubbles can be monitored aurally, with Doppler ultrasound, or visually, with two dimensional (2D) ultrasound imaging. Doppler grades and imaging grades can be compared with good agreement. Early 2D imaging units did not provide such comprehensive observations as Doppler, but advances in technology have allowed development of improved, portable, relatively inexpensive units. Most now employ harmonic technology; it was suggested that this could allow previously undetectable bubbles to be observed. METHODS: This paper provides a review of current methods of bubble measurement and how new technology may be changing our perceptions of the potential relationship of these measurements to decompression illness. Secondly, 69 paired ultrasound images were made using conventional 2D ultrasound imaging and harmonic imaging. Images were graded on the Eftedal-Brubakk (EB) scale and the percentage agreement of the images calculated. The distribution of mismatched grades was analysed. RESULTS: Fifty-four of the 69 paired images had matching grades. There was no significant difference in the distribution of high or low EB grades for the mismatched pairs. CONCLUSIONS: Given the good level of agreement between pairs observed, it seems unlikely that harmonic technology is responsible for any perceived increase in observed bubble loads, but it is probable that our increasing use of 2D ultrasound to assess dive profiles is changing our perception of 'normal' venous and arterial bubble loads. Methods to accurately investigate the load and size of bubbles developed will be helpful in the future in determining DCS risk.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Blogg,S.L., Gennser,M., Mollerlokken,A., Brubakk,A.O.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Gender and social disparities in esophagus cancer incidence in Iran, 2003-2009: a time trend province-level study 2014 Research Center for Health Services Management, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran and Health Economics Unit, Department of Clinical Sciences, Lund University, Lund, Sweden E-mail : aliasghar.ahmad
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Asian Pacific journal of cancer prevention : APJCP
Periodical, Abbrev.
Asian Pac.J.Cancer.Prev.
Pub Date Free Form
Volume
15
Issue
2
Start Page
623
Other Pages
627
Notes
JID: 101130625; ppublish
Place of Publication
Thailand
ISSN/ISBN
1513-7368; 1513-7368
Accession Number
PMID: 24568468
Language
eng
SubFile
Journal Article; IM
DOI
Output Language
Unknown(0)
PMID
24568468
Abstract
BACKGROUND: Esophagus cancer (EC) is among the five most common cancers in both sexes in Iran, with an incidence rate well above world average. Social rank (SR) of individuals and regions are well-known independent predictors of EC incidence. The aim of current study was to assess gender and social disparities in EC incidence across Iran's provinces through 2003-2009. MATERIALS AND METHODS: Data on distribution of population at province level were obtained from the Statistical Centre of Iran. Age-standardized incidence rates of EC were gathered from the National Cancer Registry. The Human Development Index (HDI) was used to assess the province social rank. Rate ratios and Kunst and Mackenbach relative indices of inequality (RIIKM) were used to assess gender and social inequalities, respectively. Annual percentage change (APC) was calculated using joinpoint regression. RESULTS: EC incidence rate increased 4.6% and 6.5% per year among females and males, respectively. There were no gender disparities in EC incidence over the study period. There were substantial social disparities in favor of better-off provinces in Iran. These social disparities were generally the same between males and females and were stable over the study period. CONCLUSIONS: The results showed an inverse association between the provinces' social rank and EC incidence rate in Iran. In addition, I found that, in contrast with international trends, women are at the same risk of EC as men in Iran. Further investigations are needed to explain these disparities in EC incidence across the provinces.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Kiadaliri,A.A.
Original/Translated Title
URL
Date of Electronic
PMCID
Editors
Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry 2014 Septic Surgical Unit, Department of Surgery and Anesthesiology, Lausanne University Hospital, Lausanne, Switzerland.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Antimicrobial Agents and Chemotherapy
Periodical, Abbrev.
Antimicrob.Agents Chemother.
Pub Date Free Form
May
Volume
58
Issue
5
Start Page
2709
Other Pages
2717
Notes
JID: 0315061; 0 (Echinocandins); 7XU7A7DROE (Amphotericin B); 8VZV102JFY (Fluconazole); 9HLM53094I (anidulafungin); F0XDI6ZL63 (caspofungin); OID: NLM: PMC3993256; 2014/02/24 [aheadofprint]; ppublish
Place of Publication
United States
ISSN/ISBN
1098-6596; 0066-4804
Accession Number
PMID: 24566186
Language
eng
SubFile
Journal Article; Research Support, Non-U.S. Gov't; IM
DOI
10.1128/AAC.00057-14 [doi]
Output Language
Unknown(0)
PMID
24566186
Abstract
We investigated the activities of fluconazole, caspofungin, anidulafungin, and amphotericin B against Candida species in planktonic form and biofilms using a highly sensitive assay measuring growth-related heat production (microcalorimetry). C. albicans, C. glabrata, C. krusei, and C. parapsilosis were tested, and MICs were determined by the broth microdilution method. The antifungal activities were determined by isothermal microcalorimetry at 37 degrees C in RPMI 1640. For planktonic Candida, heat flow was measured in the presence of antifungal dilutions for 24 h. Candida biofilm was formed on porous glass beads for 24 h and exposed to serial dilutions of antifungals for 24 h, and heat flow was measured for 48 h. The minimum heat inhibitory concentration (MHIC) was defined as the lowest antifungal concentration reducing the heat flow peak by >/=50% (>/=90% for amphotericin B) at 24 h for planktonic Candida and at 48 h for Candida biofilms (measured also at 24 h). Fluconazole (planktonic MHICs, 0.25 to >512 mug/ml) and amphotericin B (planktonic MHICs, 0.25 to 1 mug/ml) showed higher MHICs than anidulafungin (planktonic MHICs, 0.015 to 0.5 mug/ml) and caspofungin (planktonic MHICs, 0.125 to 0.5 mug/ml). Against Candida species in biofilms, fluconazole's activity was reduced by >1,000-fold compared to its activity against the planktonic counterparts, whereas echinocandins and amphotericin B mainly preserved their activities. Fluconazole induced growth of planktonic C. krusei at sub-MICs. At high concentrations of caspofungin (>4 mug/ml), paradoxical growth of planktonic C. albicans and C. glabrata was observed. Microcalorimetry enabled real-time evaluation of antifungal activities against planktonic and biofilm Candida organisms. It can be used in the future to evaluate new antifungals and antifungal combinations and to study resistant strains.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Maiolo,E.M., Furustrand Tafin,U., Borens,O., Trampuz,A.
Original/Translated Title
URL
Date of Electronic
20140224
PMCID
PMC3993256
Editors
Prevalence and Risk Factors for Barrett's Esophagus in Patients with GERD in Northern India; Do Methylene Blue-directed Biopsies Improve Detection of Barrett's Esophagus Compared the Conventional Method? 2014 Department of Gastroenterology, India.; Resident, Department of Internal Medicine, India.; Professor, Department of Gastroenterology, India.; Student, Department of Internal Medicine, India.
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
Middle East journal of digestive diseases
Periodical, Abbrev.
Middle East.J.Dig.Dis.
Pub Date Free Form
Oct
Volume
6
Issue
4
Start Page
228
Other Pages
236
Notes
LR: 20141030; JID: 101535395; OID: NLM: PMC4208931; OTO: NOTNLM; 2014/05/21 [received]; 2014/09/09 [accepted]; ppublish
Place of Publication
Iran
ISSN/ISBN
2008-5230; 2008-5230
Accession Number
PMID: 25349686
Language
eng
SubFile
Journal Article
DOI
Output Language
Unknown(0)
PMID
25349686
Abstract
BACKGROUND The reported rates of Barrett's esophagus (BE) ranged from 2.6% to 23% in Indian patients with gastro-esophageal reflux disease (GERD) symptoms. The role of methylene blue chromoendoscopy during endoscopy, either for the diagnosis of Barrett's esophagus or for the detection of dysplasia and early cancer, remains controversial. AIM: Our study was designed to find out the endoscopic as well as histological prevalence of BE in India in a specified patient population affected by GERD, and whether methylene blue chromoendoscopy improves detection of specialized intestinal metaplasia in endoscopically suspected Barrett's esophagus in GERD patients. METHODS Three hundred and seventy eight patients with characteristic symptoms of GERD from Northern India were subjected to upper endoscopy. On endoscopic suspicion of columnar lined epithelium (CLE) either 4-quadrant conventional biopsies at 2 cm interval or Methylene Blue (MB) directed biopsies were obtained randomly. The two groups were compared for the detection of Specialized Intestinal Metaplasia (SIM), which was diagnosed if the intestinal goblet cells were present. RESULTS Out of 378 patients with GERD, 56 (14.81%) were suspected of CLE on endoscopy. After taking biopsy samples from the 56 patients, only 9 (2.38%) had specialized intestinal metaplasia on histopathological examination. Five (15.15%) patients in the conventional group and four (17.39%) patients in the chromoendoscopy group (p=0.55) were diagnosed as having BE. On univariate analysis the predictors of SIM were symptoms of reflux and length of CLE. CONCLUSION The prevalence of biopsy proven BE and CLE in Northern India was 2.38% and 14.81%, respectively in patients with symptoms of GERD. The results of MB directed biopsies were similar to conventional biopsies in detecting SIM.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Wani,I.R., Showkat,H.I., Bhargav,D.K., Samer,M.
Original/Translated Title
URL
Date of Electronic
PMCID
PMC4208931
Editors
Symptoms of tobacco dependence among middle and high school tobacco users: results from the 2012 National Youth Tobacco Survey 2014 Office of Science Rockville, Maryland. Electronic address: benjamin.apelberg@fda.hhs.gov.; Office of Science Rockville, Maryland.; Office of Science Rockville, Maryland.; Office of Science Rockville, Maryland.; Office of the Center Director, Center for To
Source Type
Print(0)
Ref Type
Journal Article
Periodical, Full
American Journal of Preventive Medicine
Periodical, Abbrev.
Am.J.Prev.Med.
Pub Date Free Form
Aug
Volume
47
Issue
2 Suppl 1
Start Page
S4
Other Pages
14
Notes
LR: 20160221; CI: Published by Elsevier Inc.; GR: CC999999/Intramural CDC HHS/United States; JID: 8704773; HHSPA726039; OID: NLM: HHSPA726039; OID: NLM: PMC4624110; 2013/11/28 [received]; 2014/04/24 [revised]; 2014/04/29 [accepted]; ppublish
Place of Publication
Netherlands
ISSN/ISBN
1873-2607; 0749-3797
Accession Number
PMID: 25044195
Language
eng
SubFile
Journal Article; IM
DOI
10.1016/j.amepre.2014.04.013 [doi]
Output Language
Unknown(0)
PMID
25044195
Abstract
BACKGROUND: A growing body of evidence suggests that tobacco dependence symptoms can occur soon after smoking onset and with low levels of use. However, limited data are available nationally and among non-cigarette tobacco users. PURPOSE: To examine the prevalence and determinants of tobacco dependence symptoms among adolescent tobacco users in the 2012 National Youth Tobacco Survey, a nationally representative, school-based survey of U.S. middle and high school students. METHODS: Multivariate logistic regression was used to identify independent predictors of dependence symptoms among current users (i.e., past 30-day use) of cigarettes, cigars, or smokeless tobacco. Analyses were conducted in 2013 using SAS-callable SUDAAN, version 11 to account for the complex survey design. RESULTS: Prevalence of tobacco dependence symptoms ranged from 20.8% (95% CI=18.6, 23.1) of current tobacco users reporting wanting to use tobacco within 30 minutes of waking to 41.9% (95% CI=39.3, 44.5) reporting recent strong cravings. Reporting of dependence symptoms was most consistently associated with polytobacco use, higher frequency of use, earlier initiation age, and female gender. A 2-4-fold increase in the odds of symptom reporting was found in adolescents using tobacco products on as few as 3-5 days compared to those who only used it for 1-2 of the past 30 days. CONCLUSIONS: A substantial proportion of U.S. adolescent tobacco users, including those with low levels of use, report symptoms of tobacco dependence. These findings demonstrate the need for full implementation of evidence-based strategies to prevent both experimentation and progression to regular tobacco use among youth.
Descriptors
Links
Book Title
Database
Publisher
Data Source
Authors
Apelberg,B.J., Corey,C.G., Hoffman,A.C., Schroeder,M.J., Husten,C.G., Caraballo,R.S., Backinger,C.L.
Original/Translated Title
URL
Date of Electronic
PMCID
PMC4624110
Editors